309 related articles for article (PubMed ID: 26275478)
1. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions.
Venkataraman A; Yusuff M; Liebeschuetz S; Riddell A; Prendergast AJ
Vaccine; 2015 Oct; 33(41):5470-5474. PubMed ID: 26275478
[TBL] [Abstract][Full Text] [Related]
2. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
[TBL] [Abstract][Full Text] [Related]
3. Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital.
Bolursaz MR; Lotfian F; Velayati AA
Allergol Immunopathol (Madr); 2017; 45(4):356-361. PubMed ID: 28161281
[TBL] [Abstract][Full Text] [Related]
4. Bacille Calmette-Guérin lymphadenitis.
Goraya JS; Virdi VS
Postgrad Med J; 2002 Jun; 78(920):327-9. PubMed ID: 12151684
[TBL] [Abstract][Full Text] [Related]
5. Management of Bacille Calmette-Guérin Lymphadenitis and Abscess in Immunocompetent Children: A Systematic Review.
Villanueva P; Pittet LF; Curtis N
Pediatr Infect Dis J; 2021 Nov; 40(11):1037-1045. PubMed ID: 34636800
[TBL] [Abstract][Full Text] [Related]
6. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.
Al-Salem AH; Kothari MR; AlHani HM; Oquaish MM; Khogeer SS; Desouky MS
Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization.
Rermruay R; Rungmaitree S; Chatpornvorarux S; Brukesawan C; Wittawatmongkol O; Lapphra K; Phongsamart W; Kongstan N; Khumcha B; Chokephaibulkit K
Vaccine; 2018 Jun; 36(28):4046-4053. PubMed ID: 29859799
[TBL] [Abstract][Full Text] [Related]
8. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.
Nazir Z; Qazi SH
J Ayub Med Coll Abbottabad; 2005; 17(4):16-8. PubMed ID: 16599027
[TBL] [Abstract][Full Text] [Related]
9. The role of surgical management of BCG vaccine-induced regional suppurative lymphadenitis in children: a 7 years' experience from one medical center.
Liu C; Huang M; Liu F; Xu X; Feng W; Han G; Liu X; Zheng B; Geng L; Fu T
BMC Infect Dis; 2021 Aug; 21(1):801. PubMed ID: 34380453
[TBL] [Abstract][Full Text] [Related]
10. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine.
Alrabiaah AA; Alsubaie SS; Bukhari EI; Gad A; Alzamel FA
Ann Saudi Med; 2012; 32(1):4-8. PubMed ID: 22156633
[TBL] [Abstract][Full Text] [Related]
11. Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.
Al-Hajoj S; Memish Z; Abuljadayel N; AlHakeem R; AlRabiah F; Varghese B
PLoS One; 2014; 9(11):e113472. PubMed ID: 25409184
[TBL] [Abstract][Full Text] [Related]
12. Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran.
Samileh N; Ahmad S; Farzaneh A; Shahnaz R; Lida F; Mohammad N
Saudi Med J; 2006 Nov; 27(11):1719-24. PubMed ID: 17106549
[TBL] [Abstract][Full Text] [Related]
13. [Adverse events following BCG vaccination].
Sagić L
Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
[TBL] [Abstract][Full Text] [Related]
14. Needle aspiration as a diagnostic tool and therapeutic modality in suppurative lymphadenitis following Bacillus Calmette Guerin vaccination.
Sataynarayana S; Mathur AD; Verma Y; Pradhan S; Bhandari MK
J Assoc Physicians India; 2002 Jun; 50():788-91. PubMed ID: 12240843
[TBL] [Abstract][Full Text] [Related]
15. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].
Cerdá de Palou E; de Santy HP
Ned Tijdschr Geneeskd; 2003 Mar; 147(12):569-72. PubMed ID: 12693089
[TBL] [Abstract][Full Text] [Related]
16. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI(®) in Singapore.
Soh SB; Han PY; Tam KT; Yung CF; Liew WK; Tan NW; Chong CY; Thoon KC
Vaccine; 2014 Oct; 32(44):5809-15. PubMed ID: 25173482
[TBL] [Abstract][Full Text] [Related]
17. [Bacille Calmette-Guérin adenitis: diagnostic and therapeutic guidelines].
Constant C; Figueiredo A; Brito MJ
Acta Med Port; 2011 Dec; 24 Suppl 2():263-8. PubMed ID: 22849911
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral cephalexin in the treatment of BCG lymphadenitis.
Ayazi P; Mahyar A; Taremiha A; Ghorani N; Esmailzadehha N
Infez Med; 2014 Jun; 22(2):112-7. PubMed ID: 24955797
[TBL] [Abstract][Full Text] [Related]
19. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine.
Hendry AJ; Dey A; Beard FH; Khandaker G; Hill R; Macartney KK
Commun Dis Intell Q Rep; 2016 Dec; 40(4):E470-E474. PubMed ID: 28043221
[TBL] [Abstract][Full Text] [Related]
20. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
Szczuka I
Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
